BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19038358)

  • 1. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
    Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120.
    Reiser K; François KO; Schols D; Bergman T; Jörnvall H; Balzarini J; Karlsson A; Lundberg M
    Int J Biochem Cell Biol; 2012 Mar; 44(3):556-62. PubMed ID: 22230366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalysis of thiol/disulfide exchange. Glutaredoxin 1 and protein-disulfide isomerase use different mechanisms to enhance oxidase and reductase activities.
    Xiao R; Lundström-Ljung J; Holmgren A; Gilbert HF
    J Biol Chem; 2005 Jun; 280(22):21099-106. PubMed ID: 15814611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry.
    Gallina A; Hanley TM; Mandel R; Trahey M; Broder CC; Viglianti GA; Ryser HJ
    J Biol Chem; 2002 Dec; 277(52):50579-88. PubMed ID: 12218051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
    Barbouche R; Miquelis R; Jones IM; Fenouillet E
    J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding.
    Fenouillet E; Barbouche R; Courageot J; Miquelis R
    J Infect Dis; 2001 Mar; 183(5):744-52. PubMed ID: 11181151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion.
    Ou W; Silver J
    Virology; 2006 Jul; 350(2):406-17. PubMed ID: 16507315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120.
    Khan MM; Simizu S; Lai NS; Kawatani M; Shimizu T; Osada H
    ACS Chem Biol; 2011 Mar; 6(3):245-51. PubMed ID: 21121641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry.
    Markovic I; Stantchev TS; Fields KH; Tiffany LJ; Tomiç M; Weiss CD; Broder CC; Strebel K; Clouse KA
    Blood; 2004 Mar; 103(5):1586-94. PubMed ID: 14592831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reexamination of the role of interplay between glutathione and protein disulfide isomerase.
    Lappi AK; Ruddock LW
    J Mol Biol; 2011 Jun; 409(2):238-49. PubMed ID: 21435343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of polyanion-resistance on HIV-1 infection.
    Bobardt MD; Armand-Ugón M; Clotet I; Zhang Z; David G; Este JA; Gallay PA
    Virology; 2004 Aug; 325(2):389-98. PubMed ID: 15246277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 16. Snapshot of the interaction between HIV envelope glycoprotein 120 and protein disulfide isomerase.
    Wang Z; Zhou Z; Guo ZY; Chi CW
    Acta Biochim Biophys Sin (Shanghai); 2010 May; 42(5):358-62. PubMed ID: 20458450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the thioredoxin system by PX-12 (1-methylpropyl 2-imidazolyl disulfide) impedes HIV-1 infection in TZM-bl cells.
    Lundberg M; Mattsson Å; Reiser K; Holmgren A; Curbo S
    Sci Rep; 2019 Apr; 9(1):5656. PubMed ID: 30948772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1.
    Berkower I; Murphy D
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1055-65. PubMed ID: 8466484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.
    Stantchev TS; Paciga M; Lankford CR; Schwartzkopff F; Broder CC; Clouse KA
    Retrovirology; 2012 Dec; 9():97. PubMed ID: 23206338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides.
    Curbo S; Gaudin R; Carlsten M; Malmberg KJ; Troye-Blomberg M; Ahlborg N; Karlsson A; Johansson M; Lundberg M
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1272-7. PubMed ID: 19878651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.